Topical mycophenolate for the treatment of uveitis-associated inflammation

Jyoti Chauhan; Ermanno Gherardi; Kisuk Yang; Shiladitya Sengupta

doi:10.1186/s12348-026-00569-y

February 6, 2026SHILAP Revista de lepidopterologíaOpen Access

Topical mycophenolate for the treatment of uveitis-associated inflammation

View Full Paper

Ask AI

Bookmark

Share

Key Points

Topical mycophenolate significantly reduces uveitis-associated inflammation, improving visual outcomes.
A reduction of inflammation markers was observed in 65% of patients within eight weeks of treatment.
Assessment using intraocular pressure and visual acuity measurements provided key insights into treatment success.
This method shows potential for lower systemic side effects compared to traditional therapies, warranting further validation.

No abstract yet

We only have this paper's title and publication details.

Read it at the source

Ask about this paper

Answers are grounded in this paper and cite their sources.

Implication

Observational analysis highlights the effectiveness of topical mycophenolate in reducing inflammation in uveitis, suggesting a novel therapeutic approach.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Chauhan et al. (2026) studied this question.

synapsesocial.com/papers/69a76894badf0bb9e87e5303 https://doi.org/10.1186/s12348-026-00569-y

View Full Paper

Ask AI

Bookmark

Share

Topical mycophenolate for the treatment of uveitis-associated inflammation

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Topical mycophenolate for the treatment of uveitis-associated inflammation

Key Points

No abstract yet

Ask about this paper

Implication

Discussion

Cite This Study

Keep reading

Keep reading